Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 01, 2025 08:00 ET | Source: AEON Biopharma Inc

AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19

AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19
September 05, 2025 08:00 ET | Source: electroCore, Inc.

electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the Board

ROCKAWAY, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the departure of Peter Cuneo from...
September 03, 2025 09:00 ET | Source: Association of Migraine Disorders

Migraine and Back-to-School: Experts Share Tips to Reduce Triggers and Support Students

Providence, RI, Sept. 03, 2025 (GLOBE NEWSWIRE) -- As the school year begins, the Association of Migraine Disorders (AMD) is highlighting the challenges students with migraine face during the...
August 12, 2025 16:05 ET | Source: AEON Biopharma Inc

AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update

AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 06, 2025 07:00 ET | Source: Teva Pharmaceutical Industries Ltd

FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine

FDA approves single-dose AJOVY® (fremanezumab-vfrm) injection for the preventive treatment of episodic migraine in children and adolescents aged 6-17 who weigh 45 kilograms or more, offering a...
July 23, 2025 08:00 ET | Source: electroCore, Inc.

electroCore to Announce Second Quarter June 30, 2025 Financial Results on Wednesday, August 6, 2025

ROCKAWAY, N.J., July 23, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial...
July 22, 2025 16:05 ET | Source: electroCore, Inc.

electroCore to Participate in Upcoming Investor Conferences

ROCKAWAY, N.J., July 22, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate...
June 16, 2025 07:00 ET | Source: Axsome Therapeutics, Inc.

Axsome Therapeutics Proudly Supports Migraine and Headache Awareness Month Alongside the Association of Migraine Disorders

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, is...
June 10, 2025 09:30 ET | Source: Association of Migraine Disorders

Shades for Migraine Drives Awareness and Action to Break Migraine Stigma

Providence, RI, June 10, 2025 (GLOBE NEWSWIRE) -- The nonprofit Association of Migraine Disorders is changing the conversation around migraine disease through its global Shades for Migraine...
June 10, 2025 07:10 ET | Source: Claimable

Claimable Honored in Fast Company’s 2025 World Changing Ideas Awards

Claimable Honored in Fast Company’s 2025 World Changing Ideas Awards. Recognition comes as Claimable expands its impact with support for GLP-1 appeals.